Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPHNE: once-daily darunavir/ritonavir pharmacokinetic validation in children with HIV
NL-OMON44252Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of darunavir and ritonavir in human immunodeficiency virus infection (HIV), sponsored by Radboud University Medical Center. Primary endpoint: Area under the plasma concentration-time curve over 24 hours. Started Jun 2015; status: active, not recruiting.
02
Drugs
darunavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON44252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44252.